These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 17948867)

  • 21. Nationwide study of clinical and molecular features of hereditary non-polyposis colorectal cancer (HNPCC) in Latvia.
    Irmejs A; Borosenko V; Melbarde-Gorkusa I; Gardovskis A; Bitina M; Kurzawski G; Suchy J; Gorski B; Gardovskis J
    Anticancer Res; 2007; 27(1B):653-8. PubMed ID: 17348456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers.
    Lipkin SM; Wang V; Stoler DL; Anderson GR; Kirsch I; Hadley D; Lynch HT; Collins FS
    Hum Mutat; 2001 May; 17(5):389-96. PubMed ID: 11317354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A proven de novo germline mutation in HNPCC.
    Kraus C; Kastl S; Günther K; Klessinger S; Hohenberger W; Ballhausen WG
    J Med Genet; 1999 Dec; 36(12):919-21. PubMed ID: 10594000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
    Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
    Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical staining for mismatch repair proteins, and its relevance in the diagnosis of hereditary non-polyposis colorectal cancer.
    Ewald J; Rodrigue CM; Mourra N; Lefèvre JH; Fléjou JF; Tiret E; Gespach C; Parc YR
    Br J Surg; 2007 Aug; 94(8):1020-7. PubMed ID: 17440950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
    van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
    Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of predictive models for germline mutations in DNA mismatch repair genes in colorectal cancer.
    Monzon JG; Cremin C; Armstrong L; Nuk J; Young S; Horsman DE; Garbutt K; Bajdik CD; Gill S
    Int J Cancer; 2010 Feb; 126(4):930-9. PubMed ID: 19653273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium.
    Burke W; Petersen G; Lynch P; Botkin J; Daly M; Garber J; Kahn MJ; McTiernan A; Offit K; Thomson E; Varricchio C
    JAMA; 1997 Mar; 277(11):915-9. PubMed ID: 9062331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
    Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A
    Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and management of hereditary colorectal cancer syndromes: Lynch syndrome as a model.
    Lynch HT; Lynch JF; Attard TA
    CMAJ; 2009 Sep; 181(5):273-80. PubMed ID: 19654196
    [No Abstract]   [Full Text] [Related]  

  • 32. Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer.
    Renkonen E; Zhang Y; Lohi H; Salovaara R; Abdel-Rahman WM; Nilbert M; Aittomaki K; Jarvinen HJ; Mecklin JP; Lindblom A; Peltomaki P
    J Clin Oncol; 2003 Oct; 21(19):3629-37. PubMed ID: 14512394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No evidence of genetic anticipation in a large family with Lynch syndrome.
    Stupart D; Goldberg P; Algar U; Vorster A; Ramesar R
    Fam Cancer; 2014 Mar; 13(1):29-34. PubMed ID: 23771324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lynch syndrome: the influence of environmental factors on extracolonic cancer risk in hMLH1 c.C1528T mutation carriers and their mutation-negative sisters.
    Blokhuis MM; Pietersen GE; Goldberg PA; Algar U; Van der Merwe L; Mbatani N; Vorster AA; Ramesar RS
    Fam Cancer; 2010 Sep; 9(3):357-63. PubMed ID: 20640520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cascade genetic testing for mismatch repair gene mutations.
    Mitchell RJ; Ferguson RK; Macdonald A; Dunlop MG; Campbell H; Porteous ME
    Fam Cancer; 2008; 7(4):293-301. PubMed ID: 18389387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poor performance of clinical prediction models: the harm of commonly applied methods.
    Steyerberg EW; Uno H; Ioannidis JPA; van Calster B;
    J Clin Epidemiol; 2018 Jun; 98():133-143. PubMed ID: 29174118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Completeness of pedigree and family cancer history for ovarian cancer patients.
    Son Y; Lim MC; Seo SS; Kang S; Park SY
    J Gynecol Oncol; 2014 Oct; 25(4):342-8. PubMed ID: 25142628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Heritable epimutations: a case study in humans].
    Galvani A; Bourc'his D
    Med Sci (Paris); 2008 May; 24(5):473-4. PubMed ID: 18466723
    [No Abstract]   [Full Text] [Related]  

  • 39. Linkage of a pedigree drawing program and database to a program for determining BRCA mutation carrier probability.
    Sand SR; DeRam DS; MacDonald DJ; Blazer KR; Weitzel JN
    Fam Cancer; 2005; 4(4):313-6. PubMed ID: 16341809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and Validation of Risk Prediction Models for Colorectal Cancer in Patients with Symptoms.
    Xu W; Mesa-Eguiagaray I; Kirkpatrick T; Devlin J; Brogan S; Turner P; Macdonald C; Thornton M; Zhang X; He Y; Li X; Timofeeva M; Farrington S; Din F; Dunlop M; Theodoratou E
    J Pers Med; 2023 Jun; 13(7):. PubMed ID: 37511678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.